Product Images Montelukast

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Montelukast NDC 0143-9649 by West Ward Pharmaceutical Corp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - monte tab alkem figure 01

Figure 1 - monte tab alkem figure 01

This appears to be a graph showing the change in height in centimeters over a period of weeks on a certain treatment. The treatment options are Montelukast Sodium, Bodiomeinasono 338mg, and a placebo. The number of participants in each treatment group is also provided.*

Chemical Structure - monte tab alkem figure 02

Chemical Structure - monte tab alkem figure 02

Figure 2 - monte tab alkem figure 03

Figure 2 - monte tab alkem figure 03

Montelukast Sodium Tablets, 10 mg - monte tab alkem figure 04

Montelukast Sodium Tablets, 10 mg - monte tab alkem figure 04

This is a description of a medication with the National Drug Code (NDC) number 0143-9649-30. Each tablet of this medication contains 10.4 mg of Montelukast Sodium, which is equivalent to 10 mg of Montelukast. The medication should be stored at room temperature ranging from 15°C to 30°C and away from moisture and light. The container should be tightly closed and kept out of the reach of children. Patients can get the patient information leaflet from the pharmacist. The medication is manufactured by Kemwell Biopharma Put. Ltd. in Bonelore, 562123 India, for Unimark Remedies Ltd. It is intended for patients who are 15 years and older. The manufacturer is West-Ward Pharmaceuticals Inc. in Eatontown, NY, USA.*

Montelukast Sodium Chewable Tablets, 4 mg - monte tab alkem figure 05

Montelukast Sodium Chewable Tablets, 4 mg - monte tab alkem figure 05

NDC 0143-9651-30 Montelukast Sodium Chewable Tablets 4 mg. This medication is intended for pediatric patients age 2-5 and each chewable tablet contains 4.2 mg Montelukast Sodium equivalent to 4 mg Montelukast. It is important to keep the medication out of reach of children and to store it at controlled room temperature, away from light and moisture. The medication contains phenylalanine, which is a component of aspartame. The product information is available for a complete understanding of its usage. Lastly, the medication is manufactured by Kemwell Biopharma Put. Ltd in Bangalore, India and distributed by West-Ward Pharmaceutical Corp. *

Montelukast Sodium Chewable Tablets, 5 mg - monte tab alkem figure 06

Montelukast Sodium Chewable Tablets, 5 mg - monte tab alkem figure 06

This is a product description for Montelukast Sodium Chewable Tablets, with each tablet containing 5.2 mg Montelukast Sodium equivalent to 5 mg Montelukast. These tablets are intended for pediatric patients between 6 to 14 years of age, as an asthma control medication. Each packaging contains 30 chewable tablets and must be kept in a tightly sealed container protected from moisture and light. The product is manufactured in India and distributed by West-Ward Pharmaceutical Corp. A patient information leaflet must be dispensed to each buyer. The typical dosage is not given in the text.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.